• 主题
高级搜索  >
历史搜索 清空历史
您现在的位置：首页> 中文期刊>其他>中国神经再生研究：英文版

中国神经再生研究：英文版

中国神经再生研究：英文版

CSCD

《中国神经再生研究（英文版）》（Neural Regeneration Research，NRR）杂志是目前唯一专注神经再生领域研究的国际性、经同行评议、开放获取期刊，官方网站为www.sjzsyj.org 和www.nrronline.org，月刊出版。NRR 杂志被SCIE、PubMed 和SCOPUS 等国际重要数据库收录，“中国科技期刊卓越行动计划”梯队期刊。 期刊发表神经损伤后的修复、保护、干预及再生研究的实验和临床研究创新性文章，神经再生领域相关的描述新理论新技术新方法的优秀文章，以及高质量的综述和观点文章。 期刊重点关注以下方向：（1）神经再生相关基础研究，包括成年神经元的转化与再生，损伤神经元的轴突和树突的修复和再生；神经再生过程中神经元、微环境、新生血管的变化；神经损伤后的干预、修复、保护与再生的组织形态学变化乃至细胞生物学或细胞分子生物学的改变；神经再生研究中的新理论、新技术、新方法。（2）神经再生相关临床研究，包括脑损伤与再生；退行性病与再生；脊髓损伤与再生；周围神经损伤与再生；视神经损伤与再生；颅神经损伤与再生。 期刊坚持严谨快速的审稿和严谨科学的编辑质量，保证文章1 个月内完成初审，优秀稿件3 个月内出版；力争用最有影响力的推广平台为每篇在期刊出版的文章带来最大的显示度，包括阅读量、下载量和引用量。
更多
  • 发文量：5876
  • 被引量：1751
  • H指数：7
  • 开始收录时间：2006,1(1)
  • CNKI综合因子：0.927
  • 维普期刊影响因子： 1.36
  • 万方期刊影响因子：0.71
  • 创刊时间：2006
  • 国内刊号/CN：11-5422/R
    国际刊号/ISSN：1673-5374
  • 发行周期：月刊
    邮发代号：8-585
  • 主管单位：中华人民共和国国家卫生委员会
    主办单位：Chinese Association of Rehabilitation Medicine;Liaoning Society for Cell Biology
中国神经再生研究：英文版-联系信息
  • 主编：Kwok-fai So;Xiao-Ming Xu
  • 电话：-
  • 邮箱：szb@nrren.org
  • 地址：Room 403A, Building 16, No.7 Area, Hepingli, Dongcheng District, Beijing
  • 邮编：100013
中国神经再生研究：英文版-获奖情况
  • • 卓越计划期刊
  • • 国家卫生计生委“首届优秀期刊”
  • • “中国科技期刊卓越行动计划”梯队期刊
  • 收录汇总
  • 刊内文献检索
  • 投稿信息

刊期浏览

中国神经再生研究：英文版 >2024年第8期

学科

年度

全选（0）
排序：
共4384条结果
  • 摘要：OBJECTIVE:To evaluate the treatment effects and safety of topiramate in migraine prophylaxis. DATA RETRIEVAL:We searched the Medline database,EMbase,Cochrane Library and China National Knowledge Infrastructure database for articles published between January 1995 and May 2011,using the key words"migraine","topiramate",and"prophylaxis". SELECTION CRITERIA:We selected randomized controlled trials of migraine patients,in which the experimental group was orally administered topiramate,and the control group was given placebo. Odds ratios(ORs)and mean differences(MDs)were calculated using a fixed effects model/random effects model.Quality evaluation and data extraction were performed independently by two researchers utilizing RevMan 5.0 software. MAIN OUTCOME MEASURES:Efficacy was recorded as the responder rate(response defined as at least a 50%reduction in average monthly migraine frequency)and change in mean monthly number of migraine days.Adverse events were recorded as the number of subjects exhibiting at least one adverse event. RESULTS:Eight randomized controlled trials were found to be appropriate,and had available data. The meta-analysis results revealed that topiramate(100 or 200 mg/d)was more effective than placebo in responder rate(OR=2.97,95%confidence interval(CI):2.17-4.08,P<0.01;OR=2.35, 95%CI:1.77-3.12,P<0.01).Topiramate(100 mg/d)was more effective than placebo in terms of the change in mean monthly migraine days(MD:-1.14,95%CI:-1.69 to-0.59,P<0.01).The total incidence rate of adverse events for topiramate was higher than in the placebo group(P<0.01),but most adverse events were mild to moderate. CONCLUSION:Overall,topiramate obtained good outcomes and safety in migraine prophylaxis.
  • 摘要：OBJECTIVE: To identify global research trends in stem cell transplantation for treating Duchenne muscular dystrophy using a bibliometric analysis of Web of Science. DATA RETRIEVAL: We performed a bibliometric analysis of studies on stem cell transplantation for treating Duchenne muscular dystrophy from 2002 to 2011 retrieved from Web of Science. SELECTION CRITERIA: Inclusion criteria: (a) peer-reviewed published articles on stem cell transplantation for treating Duchenne muscular dystrophy indexed in Web of Science; (b) original research articles, reviews, meeting abstracts, proceedings papers, book chapters, editorial material, and news items; and (c) publication between 2002 and 2011. Exclusion criteria: (a) articles that required manual searching or telephone access; (b) documents that were not published in the public domain; and (c) corrected papers. MAIN OUTCOME MEASURES: (1) Annual publication output; (2) distribution according to subject areas; (3) distribution according to journals; (4) distribution according to country; (5) distribution according to institution; (6) distribution according to institution in China; (7) distribution according to institution that cooperated with Chinese institutions; (8) top-cited articles from 2002 to 2006; (9) top-cited articles from 2007 to 2011. RESULTS: A total of 318 publications on stem cell transplantation for treating Duchenne muscular dystrophy were retrieved from Web of Science from 2002 to 2011, of which almost half derived from American authors and institutes. The number of publications has gradually increased over the past 10 years. Most papers appeared in journals with a focus on gene and molecular research, such as Molecular Therapy, Neuromuscular Disorders, and PLoS One. The 10 most-cited papers from 2002 to 2006 were mostly about different kinds of stem cell transplantation for muscle regeneration, while the 10 most-cited papers from 2007 to 2011 were mostly about new techniques of stem cell transplantation for treating Duchenne muscular dystrophy. CONCLUSION: The publications on stem cell transplantation for treating Duchenne muscular dystrophy were relatively few. It also needs more research to confirm that stem cell therapy is a reliable treatment for Duchenne muscular dystrophy.
  • 摘要：INVITED ARTICLES Invited Reviews-Submit an outline for your manuscript before writing and submit the manuscript within 2 months after receiving permission from NRR editorial committee.-Word limit:6,000 words maximum including
  • 摘要：Damage from spinal cord injury occurs in two phases-the trauma of the initial mechanical insult and a secondary injury to nervous tissue spared by the primary insult.Apart from damage sustained as a result of direct trauma to the spinal cord,the post-traumatic inflammatory response contributes significantly to functional motor deficits exacerbated by the secondary injury.Attenuating the detrimental aspects of the inflammatory response is a promising strategy to potentially ameliorate the secondary injury,and promote significant functional recovery.This review details how the inflammatory component of secondary injury to the spinal cord can be treated currently and in the foreseeable future.
  • 摘要：The lack of curative therapies for neurodegenerative diseases has high economic impact and places huge burden on the society.The contribution of stem cells to cure neurodegenerative diseases has been unraveled and explored extensively over the past few years.Beyond substitution of the lost neurons,stem cells act as immunomodulators and neuroprotectors.A large number of preclinical and a small number of clinical studies have shown beneficial outcomes in this context.In this review,we have summarized the current concepts of stem cell therapy in neurodegenerative diseases and the recent advances in this field,particularly between 2010 and 2012.Further studies should be encouraged to resolve the clinical issues and vague translational findings for maximum optimization of the efficacy of stem cell therapy in neurodegenerative diseases.
  • 摘要：OBJECTIVE: Precision radiotherapy plays an important role in the management of brain tumors. This study aimed to identify global research trends in precision radiotherapy for brain tumors using a bibliometric analysis of the Web of Science. DATA RETRIEVAL: We performed a bibliometric analysis of data retrievals for precision radiotherapy for brain tumors containing the key words cerebral tumor, brain tumor, intensity-modulated radiotherapy, stereotactic body radiation therapy, stereotactic ablative radiotherapy, imaging-guided radiotherapy, dose-guided radiotherapy, stereotactic brachytherapy, and stereotactic radiotherapy using the Web of Science. SELECTION CRITERIA: Inclusion criteria: (a) peer-reviewed articles on precision radiotherapy for brain tumors which were published and indexed in the Web of Science; (b) type of articles: original research articles and reviews; (c) year of publication: 2002-2011. Exclusion criteria: (a) articles that required manual searching or telephone access; (b) Corrected papers or book chapters. MAIN OUTCOME MEASURES: (1) Annual publication output; (2) distribution according to country; (3) distribution according to institution; (4) top cited publications; (5) distribution according to journals; and (6) comparison of study results on precision radiotherapy for brain tumors. RESULTS: The stereotactic radiotherapy, intensity-modulated radiotherapy, and imaging-guided radiotherapy are three major methods of precision radiotherapy for brain tumors. There were 260 research articles addressing precision radiotherapy for brain tumors found within the Web of Science. The USA published the most papers on precision radiotherapy for brain tumors, followed by Germany and France. European Synchrotron Radiation Facility, German Cancer Research Center and Heidelberg University were the most prolific research institutes for publications on precision radiotherapy for brain tumors. Among the top 13 research institutes publishing in this field, seven are in the USA, three are in Germany, two are in France, and there is one institute in India. Research interests including urology and nephrology, clinical neurology, as well as rehabilitation are involved in precision radiotherapy for brain tumors studies. CONCLUSION: Precision radiotherapy for brain tumors remains a highly active area of research and development.
  • 摘要：OBJECTIVE:To identify global trends in research on spinal cord injury-induced neurogenic bladder, through a bibliometric analysis using the Web of Science. DATA RETRIEVAL:We performed a bibliometric analysis of studies on spinal cord injury-induced neurogenic bladder using the Web of Science.Data retrieval was performed using key words"spinal cord injury","spinal injury","neurogenic bladder","neuropathic bladder","neurogenic lower urinary tract dysfunction","neurogenic voiding dysfunction","neurogenic urination disorder"and "neurogenic vesicourethral dysfunction". SELECTION CRITERIA:Inclusion criteria:(a)published peer-reviewed articles on spinal cord injury-induced neurogenic bladder indexed in the Web of Science;(b)type of articles:original research articles and reviews;(c)year of publication:no limitation.Exclusion criteria:(a)articles that required manual searching or telephone access;(b)Corrected papers and book chapters. MAIN OUTCOME MEASURES:(1)Annual publication output;(2)distribution according to journals; (3)distribution according to subject areas;(4)distribution according to country;(5)distribution according to institution;and(6)top cited publications. RESULTS:There were 646 research articles addressing spinal cord injury-induced neurogenic bladder in the Web of Science.Research on spinal cord injury-induced neurogenic bladder was found in the Science Citation Index-Expanded as of 1946.The United States,Ireland and Switzerland were the three major countries contributing to studies in spinal cord injury-induced neurogenic bladder in the 1970s.However,in the 1990s,the United States,the United Kingdom,the Netherlands,Germany and Japan published more papers on spinal cord injury-induced neurogenic bladder than Switzerland,and Ireland fell off the top ten countries list.In this century,the United States ranks first in spinal cord injury-induced neurogenic bladder studies,followed by France,the United Kingdom,Germany,Switzerland and Japan.Subject categories including urology, nephrology and clinical neurology,as well as rehabilitation,are represented in spinal cord injury-induced neurogenic bladder studies. CONCLUSION:From our analysis of the literature and research trends,we conclude that spinal cord injury-induced neurogenic bladder is a hot topic that will continue to generate considerable research interest in the future.
  • 摘要：About the Journal Founded in April 2006,Neural Regeneration Research(NRR;ISSN 1673-5374,e ISSN 1876-7958)is an international,peer-reviewed,open-access journal(www.nrronline.org)published monthly,with its mission focused on reporting creative scientific advancements in all areas of neural regeneration.The journal is committed to publishing articles on original experimental and clinical research,techno-
  • 摘要：General Information Neural Regeneration Research (NRR, ISSN 1673-5374) is an open access, peer-reviewed international journal focusing exclusively on the exciting field of neural regeneration research, published
  • 摘要：One of our previous studies showed that Yizhijiannao Granule,a compound Chinese medicine, effectively improved the clinical symptoms of Alzheimer's disease.In the present study,we established a model of Alzheimer's disease using beta-amyloid(25-35)in PC12 cells,and treated the cells with Yizhijiannao Granule and its four monomers,i.e.,icariin,catechin,Panax notoginseng saponins,and eleutheroside E.Flow cytometry showed that Yizhijiannao Granule-containing serum, icariin,Panax notoginseng saponins,and icariin+Panax notoginseng saponins were protective against beta-amyloid(25-35)-induced injury in PC12 cells.Icariin in combination with Panax notoginseng saponins significantly inhibited early apoptosis of PC12 cells with beta-amyloid (25-35)-induced injury compared to icariin or Panax notoginseng saponins alone.The effects of icariin+Panax notoginseng saponins were similar to the effects of Yizhijiannao Granule.The findings indicate that two of the effective monomers of Yizhijiannao Granule,icariin and Panax notoginseng saponins,can synergistically inhibit early apoptosis of PC12 cells induced by beta-amyloid(25-35).
  • 摘要：This study explored protective effects of Houshiheisan and its compound prescription of wind-dispelling drugs and deficiency-nourishing drugs on cerebral ischemia in terms of astrocyte activation and inflammatory factor expression.Results suggested that Houshiheisan lessened neuronal degeneration in the corpus striatum on the ischemic side of rats following cerebral ischemia/reperfusion injury,contributed to astrocyte activation and glial fibrillary acidic protein expression in the corpus striatum and decreased the levels of interleukin-2,interleukin-6, interleukin-1βand tumor necrosis factor-α.Factor analysis results demonstrated that deficiency-nourishing drugs were more beneficial in protecting neurons and upregulating glial fibrillary acidic protein expression than wind-dispelling drugs.However,wind-dispelling drugs were more effective in increasing the number of glial fibrillary acidic protein-positive cells and reducing inflammatory factor expression than deficiency-nourishing drugs.These indicate that different ingredients of Houshiheisan suppress cerebral ischemic injury by promoting astrocyte activation and diminishing inflammatory factor expression.
  • 摘要：A preliminary study from our research group showed that picroside II inhibited neuronal apoptosis in ischemic penumbra,reduced ischemic volume,and improved neurobehavioral function in rats with cerebral ischemia.The aim of the present study was to validate the neuroprotective effects of picroside II and optimize its therapeutic time window and dose in a rat model of cerebral ischemia.We found that picroside II inhibited cell apoptosis and reduced the expression of neuron-specific enolase,a marker of neuronal damage,in rats after cerebral ischemic injury.The optimal treatment time after ischemic injury and dose were determined,respectively,as follows:(1)2.0 hours and 10 mg/kg according to the results of toluidine blue staining;(2)1.5 hours and 10 mg/kg according to early apoptotic ratio by flow cytometry;(3)2.0 hours and 10 mg/kg according to immunohistochemical and western blot analysis;and(4)1.5 hours and 10 mg/kg according to reverse transcription polymerase chain reaction.The present findings suggest that an intraperitoneal injection of 10 mg/kg picroside II 1.5–2.0 hours after cerebral ischemic injury in rats is the optimal dose and time for therapeutic benefit.
  • 摘要：Totally three articles focusing on＂analgesic action of suspended moxibustion effect in visceral hypersensitivity rats with irritable bowel syndrome,and changes in prokineticin 1 and prokineticin receptor 1 expression in the spinal cord,enkephalins in the spinal cord and prokineticin-1 and prokineticin receptor-1 in the colon tissue during the analgesic progress＂
  • 摘要：Acute cerebral ischemia can occur secondary to embolism,cardiac arrest,hemorrhage,traumatic brain injury,edema,vascular compression,or any physiologic condition resulting in low cardiac output state.Survivors of cerebral ischemic events frequently suffer from profound disability,accounting for>$70billion in 2010 for treatment of embolic stroke in the US alone.More strikingly,the cost to treat stroke in the US is
  • 摘要：Totally three articles focusing on 'molecular biological mechanism by which gene modification and RNA interference techniques interfere Parkinson’s disease and Alzheimer’s disease' are published in three issues. We hope that our readers find these papers useful to their research.
  • 摘要：Totally three articles focusing on 'fluorine-18-fluoro-2-deoxy-D-glucose positron emission computed tomography, functional MRI and interictal single-photon emission CT images for evaluation of the disease degree and prognosis in children with epileptic encephalopathy, the abnormal manifestations of cerebral cortex in parkinsonian resting tremor and the effects of long-term anti-epileptic drug treatment on repair of cerebral perfusion abnormalities and reduced epileptiform discharges in idiopathic epilepsy'are published in three issues. We hope that our readers find these papers useful to their research.
  • 摘要：General Information Neural Regeneration Research (NRR, ISSN 1673-5374) is an open access, peer-reviewed international journal focusing exclusively on the exciting field of neural regeneration research, published 36 issues per year.NRR aims to timely publish innovative and creative basic and clinical research that reflects the highest standard of neural regeneration research, including ① Development,
  • 摘要：In 2007, Neural Regeneration Research(NRR) welcomes current clinical and basic researches on central nervous system damage and regeneration,
  • 摘要：Three articles regarding transplantation of umbilical cord mesenchmal stem cells alone or in combination with Schwann cells and feridex and polylysine complex-labeled bone marrow stromal cell transplantation (MRI tracing) for repair of sciatic nerve injury were reported in Neural
  • 摘要：Guangdong-Hongkong-Macau Institute for CNS Regeneration(GHMICR)at Jinan University was established in November,2011,converted from previous Joint Laboratory of Brain Function and Health,Jinan University&the University of Hong Kong.It is honored with Guangdong Key Laboratory of Brain Function and Disease,and Guangdong-Hongkong-Macau Collaborative Innovation Center of Tissue Regeneration and Repair.It is also qualified as a base for Masters and PhD student education in neurobiology.
  • 摘要：General Information Neural Regeneration Research (NRR, ISSN 1673-5374) is an open access, peer-reviewed international journal focusing exclusively on the exciting field of neural regeneration research,
  • 摘要：Professor Kowk-fai So,the editor-in-chief of Neural Regeneration Research,has been named a Fellow of the National Academy of Inventors(NAI)Professor Kwok-fai So,Department of Ophthalmology,Li Ka Shing,Faculty of Medicine,The University of Hong Kong(HKU),has been named a Fellow of the National Academy of Inventors(NAI).
  • 摘要：In the article titled“Target inhibition of caspase-8 alleviates brain damage after subarachnoid hemorrhage”,published on pages 1283–1289,Issue 7,Volume 15 of Neural Regeneration Research(Ke et al.,2020),there are errors as follows:-In the Graphical Abstract,SAH was written incorrectly as MCAO.-In the Discussion section,the last sentence was written incorrectly as“This finding supports the role of caspase-8 in alleviating neuroinflammation,and suggests that caspase-8 could represent a therapeutic target for treatment after middle cerebral artery occlusion”instead of“This finding supports the role of caspase-8 in alleviating neuroinflammation,and suggests that caspase-8 could represent a therapeutic target for treatment after SAH”.
  • 摘要：In the article titled“Glycogen synthase kinase-3βinhibitor SB216763 promotes DNA repair in ischemic retinal neurons”,published on pages 394–400,Issue 2,Volume 16 of Neural Regeneration Research(Zhang et al.,2021),there is an error in the author list.The author name Ying Yang was written incorrectly as Yang Ying.
  • 摘要：The latest research achievements will be presented in each periodical, including articles concerning cerebral structure and function, spinal structure and function, and peripheral nerve structure and function. Regarding structural areas of neural regeneration, we pay close attention to studies on molecular and cellular biology of nerve cells, developmental biology,

    中国神经再生研究：英文版的期刊信息

    • 曾用名：Nerve Regeneration Rearch;Neural Regeneration Rearch;中国神经再生研究(英文版)
    • 创刊时间：2006
    • 地区：CHINA MAINLAND
    • 语言：中文
    • 热门主题：SPINAL_CORD_INJURY REGENERATION 神经再生 FOLLOWING CEREBRAL_ISCHEMIA RESEARCH SPINAL_CORD HIPPOCAMPAL NEUROPROTECTION 神经退行性疾病
    • 学科分类：

      3

      NEUROSCIENCES:Q2;CELL BIOLOGY:Q3;

      Neuroscience:Developmental Neuroscience;

    中国神经再生研究：英文版的获奖情况

    • • 卓越计划期刊
    • • 国家卫生计生委“首届优秀期刊”
    • • “中国科技期刊卓越行动计划”梯队期刊

    中国神经再生研究：英文版的收录情况

    • • 化学文摘（网络版）
    • • 中国科学引文数据库（2011-2012）
    • • 中国科学引文数据库（2013-2014）
    • • 中国科学引文数据库（2015-2016）
    • • 中国科学引文数据库（2017-2018）
    • • 中国科学引文数据库（2019-2020）
    • • 开放获取期刊指南
    • • 医学文摘
    • • 哥白尼索引
    • • 日本科学技术振兴机构数据库
    • • 生物医学检索系统
    • • 科学引文索引（扩展库）
    • • 文摘与引文数据库
    • • 中国科技核心期刊

    中国神经再生研究：英文版的投稿信息

    • 期刊官方网站：点击前往
    • 通讯地址：Room 403A, Building 16, No.7 Area, Hepingli, Dongcheng District, Beijing
    • 邮编：100013
    • 邮箱：szb@nrren.org
    免费订阅本刊

    客服邮箱：kefu@zhangqiaokeyan.com

    京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有 出版物经营许可证

    • 客服微信

    • 服务号